Design, synthesis, and degradation studies of new enzymatically erodible Poly(hydroxyethyl methacrylate)/poly(ethylene oxide) hydrogels by unknown
Design, synthesis, and degradation studies of new enzymatically erodible
poly„hydroxyethyl methacrylate…/poly„ethylene oxide… hydrogels
Nawel S. Khelfallah, Gero Decher, and Philippe J. Mésinia
Institut Charles Sadron CNRS UPR 022, 6 rue Boussingault, 67083 Strasbourg, France
Received 20 July 2007; accepted 17 September 2007; published 2 November 2007
This work describes the synthesis and the study of polyhydroxyethyl methacrylate PHEMA
hydrogels, cross-linked by polyethylene oxidePEO chains containing the Gly-Gly-Leu tripeptide.
This sequence was selected for its ability to be cleaved by subtilisin, a bacterial protease. The
cross-linker was synthesized by coupling the peptide with two amino-terminated PEO chains of
Mw=3400 g/mol. The resulting polymer was characterized by size exclusion chromatography,
nuclear magnetic resonance, and mass spectroscopy, and was shown to be readily cleaved by
subtilisin. Its esteriﬁcation of the hydroxyl end groups into methacrylate afforded a macromonomer
that was used as a degradable cross-linker and copolymerized with hydroxyethylmethacrylate to
form hydrogels. The swelling ratio of the gels increases when the PEO cross-linker/polyHEMA ratio
increases. Incubation of these gels with the enzyme led to the total degradation of the gels. These
assays show that these gels can be used as drug-delivery systems where the release is triggered by
the presence of proteases. © 2007 American Vacuum Society. DOI: 10.1116/1.2799034
I. INTRODUCTION
Hydrogels have been of great interest to biomaterial
scientists1–3 because they offer interesting properties: high
water content and a good permeability toward oxygen and
metabolites. Their viscoelastic properties can be tuned to ap-
proach the mechanical properties of common human tissues.
For biomedical applications of hydrogels, the polymer net-
work has to be composed of polymers with low toxicity and
antigenicity such as polyhydroxethyl methacrylate
PHEMA, polyethylene oxide PEO, or chitosan. How-
ever, these polymers are not degradable under physiological
conditions. Degradability is essential to design, for example,
temporary prosthesis, tissue scaffolds, or devices to release
pharmaceutical molecules. It is often challenging to gather in
one single polymeric network all required functions: me-
chanical properties, biocompatibility, and degradability. A
successful strategy4–7 consists of introducing degradable
blocks such as polylactic acid or polyglycolic acid in
block copolymers that are then cross-linked for obtaining a
gel. Such gels can then undergo degradation under physi-
ological conditions with a rate that can be adjusted. For some
speciﬁc application, it is more advantageous when the deg-
radation starts only when the gels are solicited by a given
stimulus.8 Considerable work has been carried out on gels
whose degradation is triggered by pH changes9,10 or enzy-
matic action. In this last case, gels were synthesized that can
be degraded by azoreductase11–13 for drug release in the co-
lon, chymotrypsine,14,15 or by collagenases16–18 for tissue
repair.
The aim of the present study is to develop gels that can be
degraded by the action of proteases in this case using the
well-known bacterial enzyme subtilisin as a model. Here, we
report on the design and the synthesis of a new class of
PHEMA/PEO-based hydrogel Scheme 1. The cross-linker
is a PEO polymer chain and contains a short peptide spacer
whose sequence has been selected to be easily hydrolyzed by
subtilisin. When such a gel is incubated with the protein, the
enzymatic hydrolysis will cleave the cross-linkers and re-
lease the short PHEMA segments. In support of this concept,
we report on both the enzymatic assay performed on the
cross-linker and on the whole gels.
II. MATERIALS AND METHODS
A. Materials
Amino-terminated PEO was purchased from Shearwater,
triethylamine from Aldrich, N-3-dimethylamino propyl-
N-ethyl hydrochloride EDC from Fluka, subtilisin A type
VIII from Sigma; all substances were used without further
puriﬁcation. PEO Mw=8000 g/mol was puriﬁed by pre-
cipitation from diethyl ether. Succinyle-Glycine-Glycine-
Leucine SucGGL was obtained by succinylation19 of the
commercial tripeptide Gly-Gly-Leu Bachem. An aqueous
solution of 2-hydroxyethyl methacrylate 25 vol % was
washed with hexane 4200 mL to remove the
dimethacrylate. NaCl was then added to the aqueous phase
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SCHEME 1. Principle of this study: the cross-linkers incorporate a peptide
sequence that is cleaved by the protease.
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and the organic phase was dried over Na2SO4. The crude
product was distilled in vacuum to yield the pure monomer.
B. Characterization of the polymers
The average molecular weight of the polymers was esti-
mated by size exclusion chromatography SEC in THF
against PEO standards using a refractive index detector. In
addition, the molar masses were corroborated using a multi-
angle light scattering detector. Nuclear magnetic resonance
NMR measurements were performed with a 400 MHz
Bruker.
The mass spectra were recorded with an autoﬂex appara-
tus from Bruker Daltonics using the matrix assisted laser
desorption ionization MALDI technique and time-of-ﬂight
analysis. The compounds were dissolved in a water/MeOH
mixture with -cyano-4-hydroxycinnamic acid as the matrix
and NaCl as the cationization medium, and an aliquot of the
solution was dried on the target-plate. The spectrometer was
calibrated with a sample of PEO with known mass Mw
=6400 g/mol. The mass distributions observed for this
PEO sample were shown to correspond to the composition of
H2O+nC2H4O with an accuracy of 0.1 g/mol. The spectra
of the samples to be analyzed were recorded alone and com-
pared to this reference spectrum for the mass calculations.
The spectra of the same samples mixed with the standard
were also recorded and the same mass values were found.
C. Synthesis of the cross-linker
The macromonomers were synthesized according to
Scheme 2. Coupling of Suc-Gly-Gly-Leu with heterobifunc-
tional hydroxyl-amino-PEO was achieved with
N-3-dimethylaminopropyle- N-ethylcarbodiimide hydro-
chloride EDC and 1-hydroxy-7-azabenzotriazole HOBt.
O-2-aminoethyl-polyethylene oxide or H2NEOn-
NHBOC 2 eq., 0.58 mmol was mixed with Suc-Gly-Gly-
Leu 1 eq., 0.29 mmol, EDC 2.5 eq, 0.735 mmol, and
HOBt 0.1 eq, 0.029 mmol in N-methyl pyrrolidone 25
mL at room temperature. After 1 week, the reaction medium
was diluted with water 20 mL. The polymer was recovered
by extraction with dichloromethane and precipitation in di-
ethyl ether. The material obtained was dialyzed against
deionized water using a cellulose ester membrane Spectra/
Por with a cutoff molecular mass of 5000 g/mol and freeze
dried.
The macromonomers were prepared from the reaction of
HO-PEO-Suc-Gly-Gly-Leu-PEO-OH for the case of degrad-
able gels, and with PEO Mw=8000 for the gels to be used
as nondegradable reference. In a typical procedure 0.24
mmol of the respective polymer and triethyl amine 0.53
mmol, 2.2 equiv. were dissolved in THF 20 mL and meth-
acroyl chloride was added dropwise at 0 °C. The mixture
was allowed to reach 25 °C and stirred for a further 3 h. The
reaction was stopped by the addition of water 100 mL, and
the mixture was extracted with CH2Cl2. The organic phase
was washed with a phosphate buffer pH 7, dried over
Na2SO4, and ﬁnally evaporated. The residue was precipitated
in Et2O and washed repetitively with Et2O. The yield was
typically 85%.
D. Synthesis of the gels
The hydrogels were prepared by copolymerization of hy-
droxyethyl methacrylate HEMA with the above-described
cross-linker in a mixture of water-ethanol at 60 °C. A stock
solution of the initiator K2S2O8 was prepared at a concentra-
tion of 0.021 mol/l in water. All experiments were performed
in pyrex glass tubes. The polymerization was carried out
until the complete conversion of HEMA and the mac-
romonomer, which was typically reached after 72 h, and al-
ways resulted in transparent gels. The hydrogels were re-
moved from the cups and the conical bottom part was cut off
to obtain cylindrical hydrogels of 1.3 cm in diameter and 3
cm in length. To leach out the unreacted PEG as well as
residual HEMA monomers presumably entrapped in the net-
work, the hydrogels were immersed in both water and etha-
nol for 3 days each at room temperature.
E. Extractible and swelling rates
Extractible: gels were prepared as described before, but
before their extraction they were lyophilized for at least 24 h
and their dry weight W0 was measured. The gels were then
immersed in water and ethanol for 3 days each in order to
remove unreacted HEMA and PEO cross-linker, and lyo-
philized again. The dry extracted weight We was measured.






Swelling rates: Dry cylinders of the gels 1 cm diameter and
0.9 cm height were incubated in deionized water at 25 °C
and the swollen weight of each sample was recorded at regu-
lar time intervals after excess surface water was carefully
removed with Kimwipes paper. The degradation experiments
were continued until a constant weight was reached. The
swelling ratio was calculated by Eq. 2, where W1 and W0
are the weight of the gel in wet and dry state, respectively,SCHEME 2. Synthesis of the macromonomer used as cross-linking agent.
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F. Degradation of the gels
Hydrogel cylinders with diameters of 1 cm and height of
0.9 cm were incubated at 37 °C in 10 mL of phosphate
buffer solution Na2HPO4 30 mM, KH2PO4 8.7 mM, pH 7.4
that contained subtilisin 50 g/ l and 0.2 mg/mL sodium
azide to prevent any bacterial contamination and additional
protease sources.
III. RESULTS AND DISCUSSION
A. Selection of the peptide sequence
The choice of the peptide moiety was guided by results
from the literature: Subtilisin cleaves preferentially after
Leucine and, as many proteases, is not sensitive to the
residue in the P1 position. Moreover, it is known that short
peptides such as Cbz-Gly-Gly-Leu-NH2,20 Cbz-Gly-Gly-Leu
p-nitrophenylester,21 and methylcoumarin esters22 are sub-
strates for subtilisin. The fact that the P1 position can tol-
erate a wide variety of groups suggests that Gly-Gly-Leu-
PEO would also be substrate. The choice of a short sequence
offers two advantages: the synthesis is less effort consuming,
and second, short peptides have a low immugenicity. In a
preliminary study, we tested the compound BOCNH-
EO3-SucGlyGlyGlyLeu-EO3-NHBOC, where EO3 rep-
resents triethyleneoxide and NHBOC a BOC-protected ami-
nogroup. It turned out that this compound is a substrate for
subtilisin, demonstrating that when the C terminus is linked
to amino-terminated oligoethylenene oxide it is readily
cleaved by the protease.
B. Synthesis of the cross-linkers
The coupling of the peptide sequence with oligomers or
with aminoethyl-PEO was achieved with standard coupling
agents EDCI 2.5 equiv., HOBt Scheme 2. The yields were
quantitative for short oligomers. For the amino-ethyl-PEO,
the product was analyzed by SEC and showed a major peak
at Mw=8000 g/mol, which corresponds to twice the mass of
the starting polymer. This peak can unambiguously be attrib-
uted to the target compound HO-PEO-SucGlyGly-PEO-OH.
On the elugram, a second peak with a mass of Mw
=3500 g/mol can be superimposed with the signal of the
starting material, and therefore be attributed to either the
unreacted polymer or to the mono-adduct of PEO. Integra-
tion of both peaks leads to a ratio of 5 to 1 between them
and, in our hands, could not be improved. The mixture was
then puriﬁed by dialysis using cellulose ester membranes.
The best results were obtained with a membrane possessing a
cutoff of 5000. Figure 1 shows elution diagrams of the mix-
ture after different times of dialysis leading to a complete
separation only after 4 weeks. Despite the long duration of
this puriﬁcation step, the whole synthesis can be processed
easily to yield the pure polymer at a scale of 10 g. Its analy-
sis by MALDI-TOF revealed only one series of peaks, thus
suggesting a good purity of the sample Fig. 2. The masses
have a distribution in an arithmetic progression with an in-
crement of 44 g mol−1, which corresponds to the mass of the
monomer unit. The peak distribution ﬁts with the composi-
tion nC2H4O+Na+C14H25N5O5. These fragments corre-
spond to the monomer, the sodium cationization medium,
and the diamide of SucGGL respectively, which proves that
the synthesized cross-linker has the expected structure. The
mass distribution is centered around 7150 g/mol, which is in
agreement with the value obtained from size exclusion
chromatography.
C. Synthesis and characterization of the gels
The hydroxyl end groups of the polymer described above
were esteriﬁed with methacroyl chloride to yield the bifunc-
tional macromonomer MA-PEO-SucGlyGlyLeu-PEO-MA.
FIG. 1. SEC of HO-PEO-SucGGL-PEO-OH. : crude after synthesis; :
after 7 days dialysis with a cellulose ester membrane 5000 Da cut-off; :
after 4 weeks dialysis.
FIG. 2. MALDI-TOF spectrum of HO-PEO-SucGlyGlyLeu-PEO-OH.
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The degree of end-group functionalization was analyzed by
1H nuclear magnetic resonance spectroscopy NMR and es-
timated to be 80%. The polymerization of the macromono-
mer was subsequently carried out by the free radical mecha-
nism, in a 1:1 mixture of water and ethanol.
The feed content of the synthesized gels G1 to G5 is
given in Table I. In addition to the gels synthesized with the
peptide containing cross-linkers, we also synthesized gels
with a PEO cross-linker lacking the central peptide sequence
but with a molar mass Mw=8000 g/mol, very close to the
one of MA-PEO-SucGlyGlyLeu-PEO-MA. This undegrad-
able cross-linker was synthesized by acylation of amino-
terminated PEONH2-PEO-NH2, in the same way as the de-
gradable cross-linker above. These gels are denoted as GM1,
GM3, and GM4 in Table I. The content of extractable spe-
cies unreacted monomer and the polymer chains not co-
valently linked to the network was determined to be be-
tween 3 and 5%, which shows that the polymerization
reaction proceeds to high degrees of conversion.
The dried gels swell in water to form soft, rubbery, and
transparent hydrogels. The swelling rate of dried hydrogels
was studied by a general gravimetric method as described in
Sec. II. The swelling behavior of the different gels is de-
picted in Fig. 3. The hydrogels absorb water until their
weight reaches a plateau that represents the swelling ratio at
equilibrium. This ratio is very sensitive to the feed composi-
tion of the gels and increases with the EO content. The gels
from G1 to G5 have swelling ratios of 120, 100, 80, 66, and
56%, respectively, whereas their EO/HEMA feed contents
drop from 2.09 to 0.16 for G5. A very likely explanation for
this phenomenon is that PEO is more hydrophilic than
PHEMA, and therefore a higher PEO content should increase
the swelling ratio. It has also been reported that for macro-
nets, the swelling ratio in poor solvents increases when the
cross-linking rate increases.23–25
The kinetics of the swelling process also depend on the
composition of the gel. The time necessary to reach the pla-
teau is less than 48 h for G5, and increases up to 200 h for
G1; as expected, the diffusion of water is slower for higher
degrees of cross-inking.
A comparison of gels with and without a degradable pep-
tide sequence shows that the peptide sequence itself has little
inﬂuence on the swelling process. For the gel GM1, which
has a feed composition close to that of G1, the swelling ratio
is approximately 110%. Similar results were obtained for the
gels GM3/G3 and GM4/G4.
D. Degradability assays
In order to verify that the cleavable cross-linker is effec-
tively degraded by the enzyme, it was incubated with the
enzyme in physiological buffer and the resulting products
were monitored by SEC Fig. 4. The elution diagrams
showed that the peak at 7000 g/mol corresponding to the
intact cross-linker gradually disappeared, and that a peak
with a lower mass 3500 g/mol appeared and increased with
time. This shows indeed that the degradable cross-linker is a
substrate for the protease and that it is readily cleaved in its
center to yield two identical fragments with half the mass of
the starting material.
The gels were also subjected to enzymatic degradation
assays. They were incubated with a solution of the protease
50 g/mL in phosphate buffer pH 7 at 35 °C and their
residual weights were measured at different times Fig. 5 as
described in Sec. II F. In order to prevent any bacterial con-
tamination, NaN3 was added to the buffer. The gels obtained
with the degradable cross-linker underwent a slow degrada-
tion, which most likely takes place at the surface of the gel
and eventually results in their complete dissolution and the
formation of a clear solution. The reference gels without pep-
tide sequences were subjected to the same degradation con-








G1 7.63 107.9 14.3 1.87
G2 7.63 74.5 9.9 1.29
G3 7.63 27.9 3.7 0.54
G4 7.63 16.7 2.2 0.30
G5 7.63 8.4 2.1 0.15
GM1 7.63 75.0 13.6 1.77
GM3 7.63 2.5 4.5 0.59
GM4 7.63 0.8 2.3 0.30
FIG. 3. Swelling ratio of the PHEMA/PEO hydrogel. Peptide containing
gels: : G1; : G2; : G3; : G4; : G5. Model gels, without peptides:
: GM1; : GM3; : GM4.
FIG. 4. SEC of HO-PEO-SucGlyGlyLeu-PEO-OH incubated with the pro-
tease at physiological conditions 37 °C, pH 7.4.
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ditions but remained unaltered. The fact that the degradation
of the gels is triggered speciﬁcally by the presence of the
enzyme was demonstrated by incubating degradable gels un-
der the same conditions but in the absence
of a protease: the gels remained intact under these
circumstances.
The time required for the complete dissolution of the
samples increases slightly with the amount of cross-linker
used to form the gels. Cylindrical hydrogel samples of 1.3
cm in diameter and 3 cm in length were completely degraded
within 35 days in the case of G5, within 42 days in the case
of G3, and within 50 days in the case of G1. The degradation
took place by a depletion of material from the surface of the
gel without swelling of the gel prior to degradation. The
proﬁle of continuous mass observed on Fig. 5 is also indica-
tive of a surface degradation, as opposed to a bulk degrada-
tion process, where the mass of the gels would increase and
then decrease. The process of bulk degradation occurs when
the diffusion of the hydrolytic species is faster than the rate
of the hydrolysis. To the contrary, the surface degradation
occurs when the diffusion of the hydrolytic species is slow
compared to the rate of hydrolysis. In the present study, the
observed proﬁle shows that for all the gels, the network is
dense enough to slow down the diffusion of the enzyme
M=27 kDa into the gel. The decrease of the degradation
times from G1 to G5 can be attributed to the decrease of the
amount of cleavable peptides.
IV. CONCLUSION
This study shows that it is possible to design and to syn-
thesize well-deﬁned PEO macromonomers containing an en-
zymatically cleavable peptide sequence, in this case Suc-
Gly-Gly-Leu. We have shown that this polymer is a substrate
for subtilisin and is actually cleaved in its center where the
peptide sequence is located. We have copolymerized this
macromonomer with HEMA to form new types of degrad-
able gels. The capacity of the gels to absorb water increases
with increasing macromonomer content, which is likely ex-
plained by the highly hydrophilic character of the PEO.
Comparison with reference gels based on cross-linkers with-
out degradable units and on long-term stability of gels in the
absence of protease demonstrates that the only mechanism of
gel degradation is enzymatic action. The enzymes attack the
gels from their surface, thus reducing the gel volume with
time until complete dissolution of the gels. The next steps of
this work will be the inclusion of other peptide sequences to
control the degradation process with proteases from different
bacterial strains. The loading of gels with therapeutically ac-
tive molecules and their release from our degradable gels
will be also addressed.
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135 Khelfallah, Decher, and Mésini: Design, synthesis, and degradation studies 135
Biointerphases, Vol. 2, No. 4, December 2007
